Oncternal Therapeutics (ONCT) EBITDA (2019 - 2024)
Oncternal Therapeutics (ONCT) EBITDA from Jun 30, 2019 to Sep 30, 2024. The TTM Oncternal Therapeutics (ONCT) EBITDA is -$36M. You can adjust inflation or export chart.
Annual EBITDA
Quarterly EBITDA
Oncternal Therapeutics (ONCT) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -18.24% |
| 3 Years TTM | +11.20% |
| 5 Years TTM | +6.24% |
| All Time TTM | +15.61% |
Annual EBITDA change of Oncternal Therapeutics (ONCT)
| Year | EBITDA | Change |
|---|---|---|
| 2024 | -$26M | -36.90% |
| 2023 | -$42M | -7.21% |
| 2022 | -$45M | +43.29% |
| 2021 | -$31M | +78.85% |
| 2020 | -$18M | -47.03% |
| 2019 | -$33M | N/A |